Silibinin: where is the ethical conundrum?
From the Toxicology Section, Division of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO. Electronic address: mullinsm@wusm.wustl.edu.
Michael E
ME
Mullins
From the Toxicology Section, Division of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO.
Evan S
ES
Schwarz
From the Toxicology Section, Division of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO.
William H
WH
Dribben
From the Toxicology Section, Division of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO.
S Eliza
SE
Halcomb
From the Toxicology Section, Division of Emergency Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO.
Anna M
AM
Arroyo-Plasencia
D058186:Acute Kidney Injury / Q000188:drug therapy*; D000975:Antioxidants / Q000627:therapeutic use*; D006801:Humans; D017114:Liver Failure, Acute / Q000188:drug therapy*; D008297:Male; D009145:Mushroom Poisoning / Q000188:drug therapy*; D012838:Silymarin / Q000627:therapeutic use*
D000975:Antioxidants; D012838:Silymarin